Hereditary Nonpolyposis Colorectal Cancer
|
0.900 |
Biomarker
|
disease |
CTD_human |
Germ line hemiallelic methylations of MLH1 or MSH2 are termed as epimutations and have been identified as causative of Lynch syndrome.
|
25701956 |
2015 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.900 |
GermlineCausalMutation
|
disease |
ORPHANET |
Segregation of a novel MLH1 mutation in an Iranian Lynch syndrome family.
|
26149658 |
2015 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.900 |
Biomarker
|
disease |
CTD_human |
A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants.
|
22102614 |
2012 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.900 |
GermlineCausalMutation
|
disease |
ORPHANET |
We expect to detect the mutation in other LS patients from the region, and recommend cost-effective screening for this mutation by restriction fragment length polymorphism-polymerase chain reaction or DNA sequencing of MLH1 Exon5 prior to full genetic testing in all LS suspects of Macedonian ancestry.
|
23100212 |
2012 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.900 |
Biomarker
|
disease |
CTD_human |
Moreover, an MLH1-NES mutation detected in a patient with Lynch syndrome showed normal MMR activity but led to significantly impaired cytoplasmic transport after actinomycin D treatment.
|
21064154 |
2011 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.900 |
Biomarker
|
disease |
CTD_human |
The hereditary colon and endometrium cancer predisposition Lynch Syndrome (also called HNPCC) is caused by a germ-line mutation in one of the DNA mismatch repair (MMR) genes.
|
20020535 |
2010 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.900 |
Biomarker
|
disease |
CTD_human |
Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations.
|
14756672 |
2004 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database.
|
24362816 |
2014 |
Torre-Muir syndrome
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm.
|
25006859 |
2014 |
Torre-Muir syndrome
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome.
|
25197397 |
2014 |
Torre-Muir syndrome
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database.
|
24362816 |
2014 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
|
23788249 |
2013 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Agenesis of the corpus callosum and gray matter heterotopia in three patients with constitutional mismatch repair deficiency syndrome.
|
22692065 |
2013 |
Turcot syndrome (disorder)
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Constitutional mismatch repair-deficiency syndrome.
|
20442441 |
2010 |
Colorectal Carcinoma
|
0.800 |
Biomarker
|
disease |
CTD_human |
Tumour samples from 73 CRC patients who were treated in advanced stage with either irinotecan alone or in combination with 5-FU/leucovorin, were analysed for expression of Bcl-2, hMLH1 and hMSH2 using immunohistochemistry.
|
18949393 |
2008 |
Colorectal Carcinoma
|
0.800 |
Biomarker
|
disease |
CTD_human |
We analyzed sporadic CRCs in Omani (of African origin, N = 61), Iranian (of Caucasian origin, N = 53) and African American (N = 95) patients for microsatellite instability, expression status of mismatched repair genes (hMLH1, hMSH2) and presence of the BRAF (V600E) mutation.
|
18718023 |
2008 |
Colorectal Carcinoma
|
0.800 |
Biomarker
|
disease |
CTD_human |
Moreover, a multivariate analysis revealed that hMLH1 mRNA expression was a significant independent prognostic factor for tumor recurrence in CRC patients treated with adjuvant 5-FU.
|
18497967 |
2008 |
Colorectal Carcinoma
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Classification of ambiguous mutations in DNA mismatch repair genes identified in a population-based study of colorectal cancer.
|
18033691 |
2008 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Zebrafish with mutations in mismatch repair genes develop neurofibromas and other tumors.
|
18593904 |
2008 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.
|
17440981 |
2007 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.
|
17440981 |
2007 |
Turcot syndrome (disorder)
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.
|
17440981 |
2007 |
Colorectal Carcinoma
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
The new MLH1 variant confers a high risk of CRC and identifies a previously unrecognized mechanism in microsatellite-stable tumors.
|
15184898 |
2004 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
HNPCC mutation MLH1 P648S makes the functional protein unstable, and homozygosity predisposes to mild neurofibromatosis type 1.
|
15139004 |
2004 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
A homozygous MSH6 mutation in a child with café-au-lait spots, oligodendroglioma and rectal cancer.
|
15340263 |
2004 |